Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
about
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets.Dihydroartemisinin increases apoptosis of colon cancer cells through targeting Janus kinase 2/signal transducer and activator of transcription 3 signaling.A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.
P2860
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@en
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@nl
type
label
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@en
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@nl
prefLabel
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@en
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.
@nl
P2093
P2860
P356
P1476
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
@en
P2093
Alycia Noë
Bahram Sharif-Askari
David Davidson
Fatemeh Hasheminasab
Justin Panasci
Lawrence Panasci
Lilian Amrein
Lorena Rosca
Raquel Aloyz
Yunzhe Wang
P2860
P356
10.3389/FPHAR.2015.00147
P577
2015-07-22T00:00:00Z